Published in Cancer Imaging on March 18, 2010
Cross-sectional imaging work-up of adrenal masses. World J Radiol (2013) 0.89
Multiparametric PET/CT in oncology. Cancer Imaging (2012) 0.84
Adrenal lesions: spectrum of imaging findings with emphasis on multi-detector computed tomography and magnetic resonance imaging. J Clin Imaging Sci (2013) 0.75
Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology (2002) 2.67
Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest (2006) 2.53
Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology (2005) 1.91
Predictive value of benign percutaneous adrenal biopsies in oncology patients. Clin Radiol (2002) 1.68
The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol (2008) 1.67
Integrated PET-CT for the characterization of adrenal gland lesions in cancer patients: diagnostic efficacy and interpretation pitfalls. Radiographics (2006) 1.59
Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol (1998) 1.57
18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med (2001) 1.56
Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology (2000) 1.50
Imaging of adrenal incidentalomas: current status. AJR Am J Roentgenol (2002) 1.49
Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR Am J Roentgenol (1996) 1.33
PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients. AJR Am J Roentgenol (2009) 1.26
Nonfunctioning adrenal masses: incidental discovery on computed tomography. AJR Am J Roentgenol (1982) 1.26
Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology (1991) 1.25
CT time-attenuation washout curves of adrenal adenomas and nonadenomas. AJR Am J Roentgenol (1998) 1.22
Molecular genetics of adrenocortical tumours, from familial to sporadic diseases. Eur J Endocrinol (2005) 1.21
Percutaneous adrenal biopsy: review of a 10-year experience. Radiology (1994) 1.18
Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy--initial experience. Radiology (2006) 1.17
Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology (1996) 1.12
18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients. J Clin Endocrinol Metab (2009) 1.12
[11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings. J Clin Endocrinol Metab (2006) 1.11
Isolated adrenal masses in nonsmall-cell bronchogenic carcinoma. Radiology (1984) 1.06
Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions. AJR Am J Roentgenol (1999) 1.05
Low-density pheochromocytoma on CT: a mimicker of adrenal adenoma. AJR Am J Roentgenol (2003) 1.04
Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role? Radiology (2004) 1.03
Adrenal masses: CT characterization with histogram analysis method. Radiology (2003) 1.01
Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT. Radiology (1998) 1.00
Importance of adrenal incidentaloma in patients with a history of malignancy. Surgery (2004) 1.00
Differentiating adrenal adenomas from nonadenomas using (18)F-FDG PET/CT: quantitative and qualitative evaluation. Acad Radiol (2007) 0.98
Percutaneous CT-guided biopsy of adrenal masses: immediate and delayed complications. J Comput Assist Tomogr (1995) 0.96
Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas. AJR Am J Roentgenol (2004) 0.94
Adrenal masses: evaluation with fast gradient-echo MR imaging and Gd-DTPA-enhanced dynamic studies. Radiology (1989) 0.94
Adrenal masses: differentiation with chemical shift, fast low-angle shot MR imaging. Radiology (1993) 0.94
Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses. Eur J Radiol (2007) 0.94
Minor morphologic abnormalities of adrenal glands at CT: prognostic importance in patients with lung cancer. Radiology (2005) 0.94
Adrenal radiology: distinguishing benign from malignant adrenal masses. AJR Am J Roentgenol (1996) 0.94
Computed tomography of diffuse, non-metastatic enlargement of the adrenal glands in patients with malignant disease. Clin Radiol (1994) 0.93
Value of chemical shift subtraction MRI in characterization of adrenal masses. AJR Am J Roentgenol (2006) 0.92
Lipid-poor adenomas on unenhanced CT: does histogram analysis increase sensitivity compared with a mean attenuation threshold? AJR Am J Roentgenol (2008) 0.91
Characterization of adrenal masses (< 5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures. AJR Am J Roentgenol (1995) 0.90
Non-invasive evaluation of the incidentally detected indeterminate adrenal mass. Best Pract Res Clin Endocrinol Metab (2005) 0.89
Comparison of CT histogram analysis and chemical shift MRI in the characterization of indeterminate adrenal nodules. AJR Am J Roentgenol (2006) 0.87
Adrenal masses differentiated by MR. Radiology (1986) 0.86
Differentiation of adrenal adenomas from nonadenomas using CT histogram analysis method: a prospective study. Eur J Radiol (2009) 0.85
Adrenal tissue characterization using MR imaging. Radiology (1986) 0.84
Current role of positron emission tomography in thoracic oncology. Thorax (1998) 0.84
Adrenal adenomas: characteristic postgadolinium capillary blush on dynamic MR imaging. J Magn Reson Imaging (2001) 0.83
Non-small cell lung cancer: FDG-PET imaging. J Thorac Imaging (1999) 0.82
Evaluation of adrenal masses with gadolinium enhancement and fat-suppressed MR imaging. J Magn Reson Imaging (1993) 0.81
Adrenal enlargement and failure of suppression of circulating cortisol by dexamethasone in patients with malignancy. Br J Cancer (1999) 0.81
CT histogram analysis in pathologically proven adrenal masses. AJR Am J Roentgenol (2006) 0.79
Adrenal gland: MR imaging. Radiology (1987) 0.79
Adrenal adenomas: characteristic hyperintense rim sign on fat-saturated spin-echo MR images. Radiology (1994) 0.78
Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol (2010) 4.15
The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. J Clin Endocrinol Metab (2005) 2.80
Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology (2002) 2.67
Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions. AJR Am J Roentgenol (2008) 2.29
Urinary tract abnormalities: initial experience with multi-detector row CT urography. Radiology (2002) 2.23
Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys (2005) 2.00
Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2004) 1.90
123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation. Clin Endocrinol (Oxf) (2008) 1.78
Adrenal phaeochromocytoma: correlation of MRI appearances with histology and function. Eur Radiol (2008) 1.68
Imaging manifestations of Meckel's diverticulum. AJR Am J Roentgenol (2007) 1.65
T2-weighted MR imaging in the assessment of cirrhotic liver. Radiology (2004) 1.61
A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys (2012) 1.60
Typical and atypical presentations of extramedullary hemopoiesis. AJR Am J Roentgenol (2002) 1.52
Differentiation of papillary renal cell carcinoma subtypes on CT and MRI. AJR Am J Roentgenol (2013) 1.47
Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Radiology (2005) 1.44
Fistulas in malignant gynecologic disease: etiology, imaging, and management. Radiographics (2009) 1.43
The anatomy of the perineal membrane: its relationship to injury in childbirth and episiotomy. Aust N Z J Obstet Gynaecol (2002) 1.42
Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology (2003) 1.42
Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers. Clin Endocrinol (Oxf) (2008) 1.32
Medical decision making regarding computed tomographic radiation dose and associated risk: the patient's perspective. Arch Intern Med (2009) 1.31
CT and MR imaging of unusual locations of extra-adrenal paragangliomas (pheochromocytomas). Eur Radiol (2004) 1.29
Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol (2005) 1.22
Can CT features be used to diagnose surgical adult bowel intussusceptions? AJR Am J Roentgenol (2009) 1.21
The optimal imaging of adrenal tumours: a comparison of different methods. Endocr Relat Cancer (2007) 1.19
Imaging of neuroendocrine tumours (CT/MR/US). Best Pract Res Clin Endocrinol Metab (2007) 1.17
Lack of tumor seeding of hepatocellular carcinoma after percutaneous needle biopsy using coaxial cutting needle technique. AJR Am J Roentgenol (2006) 1.17
A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer. Cancer (2013) 1.16
Characterization of adnexal mass lesions on MR imaging. AJR Am J Roentgenol (2003) 1.16
MRI of adrenal and extraadrenal pheochromocytoma. AJR Am J Roentgenol (2005) 1.16
Lymphoma of the spleen. Semin Ultrasound CT MR (2007) 1.10
Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial. J Comput Assist Tomogr (2010) 1.10
Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours. Endocr Relat Cancer (2009) 1.09
The prediction of radiation-induced liver dysfunction using a local dose and regional venous perfusion model. Med Phys (2007) 1.09
Liver function after irradiation based on computed tomographic portal vein perfusion imaging. Int J Radiat Oncol Biol Phys (2007) 1.08
Phase I study of oxaliplatin, full-dose gemcitabine, and concurrent radiation therapy in pancreatic cancer. J Clin Oncol (2007) 1.08
Incidence of acute appendicitis in patients with equivocal CT findings. AJR Am J Roentgenol (2005) 1.04
Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid as an intrabiliary contrast agent: preliminary assessment. AJR Am J Roentgenol (2002) 1.03
Long-term changes in circulating CD4 T lymphocytes in virologically suppressed patients after 6 years of highly active antiretroviral therapy. AIDS (2004) 1.03
Distinct mechanisms of T cell reconstitution can be identified by estimating thymic volume in adult HIV-1 disease. J Infect Dis (2005) 1.00
Pneumatosis and portal venous gas: do CT findings reassure? J Surg Res (2013) 1.00
Nephrogenic systemic fibrosis: a report of 29 cases. AJR Am J Roentgenol (2008) 0.99
Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association. Radiology (2014) 0.98
Insulinomas may present with normoglycemia after prolonged fasting but glucose-stimulated hypoglycemia. J Clin Endocrinol Metab (2006) 0.98
Multimodality diagnosis of liver tumors: feature analysis with CT, liver-specific and contrast-enhanced MR, and a computer model. Acad Radiol (2002) 0.98
Effectiveness of MR imaging in characterizing small hepatic lesions: routine versus expert interpretation. AJR Am J Roentgenol (2003) 0.97
Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma. Eur J Nucl Med Mol Imaging (2003) 0.96
A verification study of proposed pelvic lymph node localisation guidelines using nanoparticle-enhanced magnetic resonance imaging. Radiother Oncol (2008) 0.95
Adrenocortical carcinoma: the range of appearances on CT and MRI. AJR Am J Roentgenol (2011) 0.94
Interventional therapies for hepatocellular carcinoma. Cancer Imaging (2012) 0.93
Renal vein leiomyosarcoma: imaging and clinical features of a renal cell carcinoma mimic. Abdom Imaging (2013) 0.92
Assessment of tumor invasion of the vena caval wall in renal cell carcinoma cases by magnetic resonance imaging. J Urol (2002) 0.92
CT and MR imaging of the adrenal glands in ACTH-independent cushing syndrome. Radiographics (2004) 0.91
Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic association. Gastroenterology (2014) 0.90
MR imaging of carcinoma of the vulva. AJR Am J Roentgenol (2002) 0.90
Biliary imaging with Gd-EOB-DTPA: is a 20-minute delay sufficient? Acad Radiol (2002) 0.90
MRI for preoperative staging of renal cell carcinoma using the 1997 TNM classification: comparison with surgical and pathologic staging. AJR Am J Roentgenol (2004) 0.89
Non-invasive evaluation of the incidentally detected indeterminate adrenal mass. Best Pract Res Clin Endocrinol Metab (2005) 0.89
Primary and secondary disease of the peritoneum and mesentery: review of anatomy and imaging features. Abdom Imaging (2015) 0.89
Making cost-effectiveness analyses clinically relevant: the effect of provider expertise and biliary disease prevalence on the economic comparison of alternative diagnostic strategies. Acad Radiol (2003) 0.88
Hepatic arterial phase MR imaging with automated bolus-detection three-dimensional fast gradient-recalled-echo sequence: comparison with test-bolus method. Radiology (2003) 0.88
Imaging appearance of renal epithelioid angiomyolipomas. J Comput Assist Tomogr (2013) 0.87
Comparison of urinary tract distension and opacification using single-bolus 3-Phase vs split-bolus 2-phase multidetector row CT urography. J Comput Assist Tomogr (2007) 0.87
A prospective evaluation of postural stimulation testing, computed tomography and adrenal vein sampling in the differential diagnosis of primary aldosteronism. Clin Endocrinol (Oxf) (2012) 0.87
Perforation of a malignant ovarian tumor into the recto-sigmoid colon. Acta Obstet Gynecol Scand (2010) 0.87
Gemcitabine-based combination chemotherapy followed by radiation with capecitabine as adjuvant therapy for resected pancreas cancer. Int J Radiat Oncol Biol Phys (2009) 0.87
Magnetic resonance imaging features of renal synovial sarcoma: a case report. Cancer Imaging (2008) 0.87
CT, MRI and PET imaging in peritoneal malignancy. Cancer Imaging (2011) 0.87
CT appearances following laparoscopic partial nephrectomy for renal cell carcinoma using a rolled cellulose bolster. Cancer Imaging (2010) 0.86
Evaluation of imaging-guided core biopsy of pancreatic masses. AJR Am J Roentgenol (2006) 0.85
Characterization of adrenal masses with diffusion-weighted imaging. AJR Am J Roentgenol (2011) 0.85
Imaging of pancreas transplants: postoperative findings with clinical correlation. J Comput Assist Tomogr (2009) 0.85
Older HIV-infected patients on antiretroviral therapy have B-cell expansion and attenuated CD4 cell increases with immune activation reduction. AIDS (2013) 0.85
Multimodality imaging in ureteric and periureteric pathologic abnormalities. AJR Am J Roentgenol (2011) 0.84
Evaluation of imaging-guided core biopsy of pelvic masses. AJR Am J Roentgenol (2007) 0.84
Mimics of pancreatic ductal adenocarcinoma. Cancer Imaging (2013) 0.84
MR imaging appearances of the female pelvis after trachelectomy. Radiographics (2005) 0.84
Imaging of endometrial and cervical cancer. Insights Imaging (2010) 0.83
Ovarian Cancer Management: the role of imaging and diagnostic challenges. Eur J Radiol (2011) 0.83
MRI appearances of uterine malignant mixed müllerian tumors. AJR Am J Roentgenol (2010) 0.83
Imaging effects of radiation therapy in the abdomen and pelvis: evaluating "innocent bystander" tissues. Radiographics (2013) 0.82
Extra Z-axis coverage at CT imaging resulting in excess radiation dose: frequency, degree, and contributory factors. J Comput Assist Tomogr (2011) 0.82
Vascular pancreatic lesions: spectrum of imaging findings of malignant masses and mimics with pathologic correlation. Abdom Imaging (2013) 0.82
3D excretory MR urography: improved image quality with intravenous saline and diuretic administration. J Magn Reson Imaging (2007) 0.81
Multimodality imaging of splenic lesions and the role of non-vascular, image-guided intervention. Abdom Imaging (2014) 0.81
CT imaging characteristics of oncocytic adrenal neoplasms (OANs): comparison with adrenocortical carcinomas. Abdom Imaging (2014) 0.81
Imaging of acute pancreatitis: prognostic value of computed tomographic findings. J Comput Assist Tomogr (2010) 0.81
Detection of upper tract urothelial neoplasms: sensitivity of axial, coronal reformatted, and curved-planar reformatted image-types utilizing 16-row multi-detector CT urography. Abdom Imaging (2008) 0.81
Hyperplasia of adrenal rest tissue causing a retroperitoneal mass in a child with 11 beta-hydroxylase deficiency. Horm Res (2003) 0.80
Imaging and management of the incidentally discovered renal mass. Cancer Imaging (2009) 0.80
Prognostic significance of carbohydrate antigen 19-9 in unresectable locally advanced pancreatic cancer treated with dose-escalated intensity modulated radiation therapy and concurrent full-dose gemcitabine: analysis of a prospective phase 1/2 dose escalation study. Int J Radiat Oncol Biol Phys (2012) 0.80
Computed tomography appearances of hypervascular hepatic tumors after percutaneous radiofrequency ablation therapy. Curr Probl Diagn Radiol (2002) 0.80
Comparative investigation of i.v. iohexol and iopamidol: effect on renal function in low-risk outpatients undergoing CT. AJR Am J Roentgenol (2012) 0.79
Adrenal Incidentaloma triage with single-source (fast-kilovoltage switch) dual-energy CT. AJR Am J Roentgenol (2014) 0.78
Imaging in covert ectopic ACTH secretion: a CT pictorial review. Eur Radiol (2009) 0.78
Imaging in Cushing's syndrome. Arq Bras Endocrinol Metabol (2007) 0.78
Pearls and pitfalls of MR lymphography in gynecologic malignancy. Radiographics (2009) 0.78
Magnetic resonance imaging of endometrial and cervical cancer. Ann N Y Acad Sci (2008) 0.78
Radiologic evaluation of incidentally discovered adrenal masses. Am Fam Physician (2010) 0.77